Microrna Expression Profiles Associated With Response To Adalimumab and Methotrexate Versus Methotrexate: A Placebo-Controlled Clinical Trial

被引：0

作者：

Krintel, Sophine B. ^{[1
,2
]}

Dehlendorff, Christian ^{[3
]}

Hetland, Merete L. ^{[4
]}

Horslev-Petersen, Kim ^{[5
]}

Andersen, Klaus K. ^{[3
]}

Junker, Peter ^{[6
]}

Podenphant, Jan ^{[7
]}

Ellingsen, Torkell ^{[8
]}

Ahlqvist, Palle ^{[9
]}

Lindegaard, Hanne M. ^{[10
]}

Linauskas, Asta ^{[11
]}

Schlemmer, Annette ^{[12
]}

Dam, Mette Y. ^{[13
]}

Hansen, Ib ^{[14
]}

Horn, Hans Chr ^{[15
]}

Jorgensen, Anette ^{[13
]}

Raun, Johnny ^{[5
]}

Ammitzboll, Christian G. ^{[13
]}

Ostergaard, Mikkel ^{[16
]}

Stengaard-Pedersen, Kristian ^{[13
]}

Johansen, Julia S. ^{[17
]}

机构：

[1] Univ Copenhagen, Copenhagen, Denmark

[2] Glostrup Cty Hosp, Copenhagen, Denmark

[3] Danish Canc Soc, Res Ctr, Copenhagen, Denmark

[4] Glostrup Univ Hosp, Ctr Rheumatol & Spine Dis, DAN BIO, Glostrup, Denmark

[5] Univ Southern Denmark, Grasten, Denmark

[6] Univ Southern Denmark, Odense, Denmark

[7] Copenhagen Univ Gentofte, Hellerup, Denmark

[8] Silkeborg Reg Hosp, Silkeborg, Denmark

[9] Univ Southern Denmark, Vejle, Denmark

[10] Odense Univ Hosp, DK-5000 Odense, Denmark

[11] Vendsyssel Hosp, Hjorring, Denmark

[12] Aalborg Univ Hosp, Aalborg, Denmark

[13] Arhus Univ Hosp, Aarhus, Denmark

[14] Viborg Hosp, Viborg, Denmark

[15] Vejle Hosp, Vejle, Denmark

[16] Copenhagen Univ Hosp Glostrup, Copenhagen, Denmark

[17] Herlev Hosp, DK-2730 Herlev, Denmark

来源：

ARTHRITIS AND RHEUMATISM | 2013年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

875

引用

页码：S374 / S375

页数：2

共 50 条

[1] Circulating Micro-RNA Profiles in Responders to Adalimumab Plus Methotrexate Versus Methotrexate Alone: A Placebo-Controlled Clinical Trial
Sode, Jacob
Krintel, Sophine B.
Carlsen, Anting L.
Hetland, Merete Lund
Johansen, Julia
Horslev-Petersen, Kim
Stengaard-Pedersen, Kristian
Junker, Peter
Ostergaard, Mikkel
Heegaard, Niels H. H.
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[2] Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial
Sode, Jacob
Krintel, Sophine B.
Carlsen, Anting Liu
Hetland, Merete L.
Johansen, Julia S.
Horsley-Petersen, Kim
Stengaard-Pedersen, Kristian
Ellingsen, Torkell
Burton, Mark
Junker, Peter
Ostergaard, Mikkel
Heegaard, Niels H. H.
JOURNAL OF RHEUMATOLOGY, 2018, 45 (01) : 53 - 61
[3] Efficacy of adalimumab compared with methotrexate or placebo stratified by baseline BMI in a randomized, placebo-controlled trial
Prussick, Ronald B.
Unnebrink, Kristina
Ghorayeb, Eric
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB233 - AB233
[4] A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
Kingsley, Gabrielle H.
Kowalczyk, Anna
Taylor, Helen
Ibrahim, Fowzia
Packham, Jonathan C.
McHugh, Neil J.
Mulherin, Diarmuid M.
Kitas, George D.
Chakravarty, Kuntal
Tom, Brian D. M.
O'Keeffe, Aidan G.
Maddison, Peter J.
Scott, David L.
RHEUMATOLOGY, 2012, 51 (08) : 1368 - 1377
[5] Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With Psoriasis
Prussick, Ronald
Unnebrink, Kristina
Valdecantos, Wendell C.
JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (08) : 864 - 868
[6] Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
Combe, Bernard
Kivitz, Alan
Tanaka, Yoshiya
van der Heijde, Desiree
Simon, J. Abraham
Baraf, Herbert S. B.
Kumar, Uma
Matzkies, Franziska
Bartok, Beatrix
Ye, Lei
Guo, Ying
Tasset, Chantal
Sundy, John S.
Jahreis, Angelika
Genovese, Mark C.
Mozaffarian, Neelufar
Landewe, Robert B. M.
Bae, Sang-Cheol
Keystone, Edward C.
Nash, Peter
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (07) : 848 - 858
[7] Comment on: A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
Sathi, Navtej
Gladston-Chelliah, Easwardhas
Chattopadhyay, Chandrabushan
RHEUMATOLOGY, 2013, 52 (04) : 761 - 761
[8] The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial
de Jong, EMGJ
Mork, NJ
Seijger, MMB
De la Brassine, M
Lauharanta, J
Jansen, CT
Guilhou, JJ
Guillot, B
Ostrojic, A
Souteyrand, P
Vaillant, L
Barnes, L
Rogers, S
Klaber, MR
van de Kerkhof, PCM
BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (02) : 318 - 325
[9] A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma
Pope, JE
Bellamy, N
Seibold, JR
Baron, M
Ellman, M
Carette, S
Smith, CD
Chalmers, IM
Hong, P
O'Hanlon, D
Kaminska, E
Markland, J
Sibley, J
Catoggio, L
Furst, DE
ARTHRITIS AND RHEUMATISM, 2001, 44 (06): : 1351 - 1358
[10] Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Tanaka, Yoshiya
Wada, Kazuteru
Takahashi, Yoshinori
Hagino, Owen
van Hoogstraten, Hubert
Graham, Neil M. H.
Kameda, Hideto
ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)

← 1 2 3 4 5 →